-
Loading metrics
Open Access
Peer-reviewed
Research Article
BRD4 amplification facilitates an oncogenic gene expression program in high-grade serous ovarian cancer and confers sensitivity to BET inhibitors
-
Garrett W. Rhyasen,
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft, Writing – review & editing
Current address: Business Insights and Analytics, Bristol-Myers Squibb, Princeton, New Jersey, United States of America
Affiliation Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Boston, Massachusetts, United States of America
⨯ -
Yi Yao,
Roles Conceptualization, Data curation, Investigation, Writing – original draft
Affiliation Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Boston, Massachusetts, United States of America
⨯ -
Jingwen Zhang,
Roles Conceptualization, Investigation, Methodology, Validation, Writing – review & editing
Affiliation Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Boston, Massachusetts, United States of America
⨯ -
Austin Dulak,
Roles Data curation, Formal analysis, Methodology, Visualization, Writing – original draft
Affiliation Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Boston, Massachusetts, United States of America
⨯ -
Lillian Castriotta,
Roles Data curation, Methodology, Validation
Affiliation Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Boston, Massachusetts, United States of America
⨯ -
Kelly Jacques,
Roles Data curation, Methodology
Affiliation Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Boston, Massachusetts, United States of America
⨯ -
Wei Zhao,
Roles Formal analysis, Methodology
Affiliation Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America
⨯ -
Farzin Gharahdaghi,
Roles Data curation, Formal analysis, Methodology, Writing – original draft
Affiliation Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Boston, Massachusetts, United States of America
⨯ -
Maureen M. Hattersley,
Roles Formal analysis, Methodology, Resources, Supervision, Writing – original draft, Writing – review & editing
Affiliation Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Boston, Massachusetts, United States of America
⨯ -
Paul D. Lyne,
Roles Conceptualization, Project administration, Supervision
Affiliation Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Boston, Massachusetts, United States of America
⨯ -
Edwin Clark,
Roles Conceptualization, Project administration, Supervision
Affiliation Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Boston, Massachusetts, United States of America
⨯ -
Michael Zinda,
Roles Conceptualization, Project administration, Supervision, Writing – review & editing
Affiliation Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Boston, Massachusetts, United States of America
⨯ -
Stephen E. Fawell,
Roles Conceptualization, Project administration, Supervision, Writing – review & editing
Affiliation Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Boston, Massachusetts, United States of America
⨯ -
Gordon B. Mills,
Roles Conceptualization, Methodology, Project administration, Resources, Supervision, Writing – review & editing
Affiliation Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America
⨯ -
Huawei Chen
Roles Conceptualization, Formal analysis, Methodology, Project administration, Supervision, Writing – original draft, Writing – review & editing
* E-mail: raymond.chen@astrazeneca.com
Affiliation Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Boston, Massachusetts, United States of America
⨯
BRD4 amplification facilitates an oncogenic gene expression program in high-grade serous ovarian cancer and confers sensitivity to BET inhibitors
- Garrett W. Rhyasen,
- Yi Yao,
- Jingwen Zhang,
- Austin Dulak,
- Lillian Castriotta,
- Kelly Jacques,
- Wei Zhao,
- Farzin Gharahdaghi,
- Maureen M. Hattersley,
- Paul D. Lyne
- Published: July 23, 2018
- https://doi.org/10.1371/journal.pone.0200826